Aster Dm Healthcare Ltd. · NSE:ASTERDM
Aster Dm Healthcare — Q3 FY21 Earnings Presentation
38 slides from Aster Dm Healthcare's earnings presentation, Feb 9, 2021
Slide 1: Cover letter to stock exchanges
February 09, 2021 The Secretary The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd 1st Floor, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai 400001 Bandra Kurla Complex Scrip Code: 540975 Bandra (East), Mumbai 40005
Slide 2: Investor Presentation – For the quarter ended 31st December 2020
Investor Presentation – For the quarter ended 31st December 2020 1
Slide 3: Disclaimer
Disclaimer This presentation has been prepared by Aster DM Healthcare Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other condit
Slide 4: Aster – Overview
Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 3
Slide 5: Aster DM Healthcare – Business Overview
Aster DM Healthcare – Business Overview HOSPITALS One of Largest Private INSTALLED CAPACITY BEDS healthcare service providers GCC: 1,165 GCC: 13 4,873 26 India: 3,708 India: 13 operating in Asia (GCC& India) PATIENT VISITS – FY21 9M Present in 7 Countries GCC: ~9.8 mn CLINICS (UAE, Saudi Arabia, Qat
Slide 6: Aster DM Healthcare – Financial Overview
Aster DM Healthcare – Financial Overview Note: 1. Revenue and EBITDA shown above excludes other income 5 2. Above shown percentage of revenue and EBITDA by hospitals, clinics and pharmacies are calculated based on gross segmental numbers before allocation of inter-segment revenue and unallocated cor
Slide 7: Geographical Footprint
Geographical Footprint Hospitals – 13 GCC Clinics – 106 Pharmacies – 225 Hospitals – 13 Clinics – 9 INDIA United Arab Emirates Kerala Medcare Hospital, Dubai Aster Medcity, Kochi Medcare Orthopaedics and Spine Hospital Aster MIMS, Calicut Aster Hospital Mankhool Aster MIMS, Kottakkal Medcare Women &
Slide 8: Hospitals List
Hospitals List Commencement/ Bed Operational Owned Hospitals - GCC Location Acquisition Year Capacity Beds /Leased Capacity Operational Geography Medcare Hospital Dubai, UAE 2007 64 55 Leased Beds Beds Al Raffah Hospital Muscat, Oman 2009 86 72 Leased Al Raffah Hospital Sohar, Oman 2010 80 69 Leased
Slide 9: Pipeline Projects
Pipeline Projects Owned / Hospitals - GCC Location Type Planned Beds Expected Completion Year Present Status Leased/O&M Aster Hospital Sharjah, UAE Greenfield 80 Q2 FY 2022 Construction Leased Aster Hospital Muscat, Oman Greenfield (Relocation) 145 Q4 FY 2022 Construction Leased Sanad Hospital Riyad
Slide 10: The Aster DM Healthcare Edge
The Aster DM Healthcare Edge Aster DM – A Healthcare Ecosystem • Presence across hospitals, clinics & pharmacies and providing primary, secondary and tertiary/ quaternary care • Strategic and sizeable network of clinics enable patient feeder structure Differentiated Asset-light Business Model in GCC
Slide 11: Aster DM Healthcare - Evolution
Aster DM Healthcare - Evolution Building the foundations New geographies, segments Brand “Aster” was formed, private equity Robust Growth across all segments and and service offerings investment, further expansion geographies; Rapid Expansion in India 2015: First clinic in Bahrain and in the Philipp
Slide 12: Robust Growth Over Last 5 Years
ROBUST GROWTH OVER LAST 5 YEARS FY 21 9M numbers has an impact of COVID ..Coupled with capacity creation for further growth # of Units FY15 FY16 FY17 FY18 FY19 FY20 FY21 9M Hospitals 14 13 18 19 24 25 26 Clinics 69 87 96 101 114 117 115 Pharmacies 166 180 202 207 219 238 225 Total 249 280 316 327 35
Slide 13: Aster – An Integrated Healthcare Provider
Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 12
Slide 14: Aster - An Integrated Healthcare Provider
Aster - An Integrated Healthcare Provider FY20 Operational Information 950+ 1,95,000+ Cardiovascular IP Discharges Surgeries ~5.8 mn 14,900+ 900+ Clinic OPD Visits General Bariatric Clinics Surgeries Surgeries $ 1 ₹ 6 0% 2,300+ Joint 1,400+ ~ 9.8 mn Replacements Spine Surgeries Pharmacy Visits 14,00
Slide 15: Aster – A Healthcare Ecosystem
Aster – A Healthcare Ecosystem Aster, over 30 years, has created a healthcare eco-system across two geographical regions In GCC region, Aster’s primary care clinics act as the initial touch-points in the patient journey, while pharmacies and hospitals continue the care For complex tertiary car
Slide 16: GCC Healthcare – Unique Traits
GCC Healthcare – Unique Traits Healthcare market in GCC states have developed certain unique traits due to the higher expat and working age population Prevalence of Primary and Secondary Healthcare Facilities (Private Sector) Due to lower % of older population requirement of tertiary and quaternar
Slide 17: Aster - Awards & Service Excellence
Aster - Awards & Service Excellence JCI Accreditation Padma Shri Award AHPI Awards Medcare Hospital Dubai, Medcare Dr. Azad Moopen, Chairman & Managing Medcity, CMI, MIMS Calicut, WIMS, Aadhar, Orthopedics and Spine Hospitals, Medcare Director – Aster DM Healthcare received Medcare , Medcare Orthope
Slide 18: Key Highlights – FY21 Q3
Key Highlights – FY21 Q3 Clinical Highlights Aster CMI successfully carried out a Heart & Lung Transplant and Bilateral Lung Transplant in December’20 Aster CMI successfully removed a Giant Right Trigeminal Schwannoma in a 30-year-old male patient after multiple sittings of tumour embolization
Slide 19: Operational and Financial Overview
Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 18
Slide 20: Revenue and Profitability Snapshot – FY21 Q3
Revenue and Profitability Snapshot – FY21 Q3 Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) Constant currency growth of Revenue, EBITDA and PAT (Post NCI) is ~-6%, ~-18% and ~-38% respectively Notes: 1. Above financials are presented in Rs. Crore 2. Percentages mentioned inside
Slide 21: Revenue and Profitability Snapshot – FY21 9M
Revenue and Profitability Snapshot – FY21 9M Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) Constant currency growth of Revenue, EBITDA and PAT (Post NCI) is ~-7%, ~-17% and ~-75% respectively Notes: 1. Above financials are presented in Rs. Crore 2. Percentages mentioned inside
Slide 22: Geography-wise Financial – Snapshot Quarterly
Geography-wise Financial – Snapshot Quarterly GCC INDIA CONSOLIDATED FY20 Q3 FY21 Q3 FY20 Q3 FY21 Q3 FY20 Q3 FY21 Q3 Revenue (₹) 1,895 Cr 1,799 Cr 427 Cr 459 Cr 2,322 Cr 2,259 Cr EBITDA (₹) 329 Cr 277 Cr 57 Cr 51 Cr 385 Cr 328 Cr PAT (Post NCI) (₹) 141 Cr 104 Cr -2 Cr -11 Cr 139 Cr 92 Cr Notes: 1. R
Slide 23: Geography-wise Financial – Snapshot 9M
Geography-wise Financial – Snapshot 9M GCC INDIA CONSOLIDATED FY20 9M FY21 9M FY20 9M FY21 9M FY20 9M FY21 9M Revenue (₹) 5,209 Cr 5,114 Cr 1,229 Cr 1,173 Cr 6,437 Cr 6,287 Cr EBITDA (₹) 704 Cr 630 Cr 150 Cr 112 Cr 854 Cr 742 Cr PAT (Post NCI) (₹) 158 Cr 107 Cr -13 Cr -64 Cr 146 Cr 42 Cr Notes: 1. R
Slide 24: Geography-wise Business – Snapshot Quarterly
Geography-wise Business – Snapshot Quarterly GCC INDIA CONSOLIDATED FY20 Q3 FY21 Q3 FY20 Q3 FY21 Q3 FY20 Q3 FY21 Q3 Total Capacity Beds 1,111 1,165 3,693 3,708 4,804 4,873 Operational Beds 920 945 2,608 2,656 3,528 3,601 ALOS (Days) 1.9 1.9 3.5 4.0 2.9 3.2 Occupancy 61% 47% 62% 61% 62% 57% Outpatien
Slide 25: Geography-wise Business – Snapshot 9M
Geography-wise Business – Snapshot 9M GCC INDIA CONSOLIDATED FY20 9M FY21 9M FY20 9M FY21 9M FY20 9M FY21 9M Total Capacity Beds 1,111 1,165 3,693 3,708 4,804 4,873 Operational Beds 920 945 2,608 2,656 3,528 3,601 ALOS (Days) 1.9 2.1 3.5 3.9 3.0 3.2 Occupancy 55% 54% 63% 54% 61% 54% Outpatient Visit
Slide 26: Segmental Performance FY21-Q3
Segmental Performance FY21-Q3 Growth % India - Unallocate India - Unallocate GCC GCC Hospitals, d& GCC GCC Hospitals, d& FY21 Q3 GCC Clinics Total GCC Clinics Total Hospitals Pharmacies Clinics and Elimination Hospitals Pharmacies Clinics and Elimination Labs s Labs s No. of Business Units (#) 13 10
Slide 27: Segmental Performance FY21-9M
Segmental Performance FY21-9M Growth % India - India - Unallocated Unallocated GCC GCC Hospitals, GCC GCC Hospitals, FY21 9M GCC Clinics & Total GCC Clinics & Total Hospitals Pharmacies Clinics and Hospitals Pharmacies Clinics and Eliminations Eliminations Labs Labs No. of Business Units (#) 13 106
Slide 28: Maturity Wise Hospital Performance – GCC FY21 9M
Maturity Wise Hospital Performance – GCC FY21 9M Key Performance indicators Revenue Maturity Hospitals Operational Beds (INR in Crs.) EBITDA ARPOBD Occupancy EBITDA % (INR in Cr.) 11% 14% ₹40 3 57% 15.9% 0-3 Years ₹ 249 136 ₹ ~129,200 Over 3 86% 53% ₹332 Years 10 89% ₹ ~ 173,300 ₹ 2094 809 15.9% 13
Slide 29: Maturity Wise Hospital Performance – India FY21 9M
Maturity Wise Hospital Performance – India FY21 9M Key Performance indicators Revenue Maturity Hospitals Operational Beds (INR in Crs.) EBITDA ARPOBD Occupancy EBITDA % (INR in Cr.) 15% 14% ₹6 0-3 Years 2 ₹ ~26,800 65% 3.3% ₹ 172 374 Over 3 86% 53% ₹130 Years 10 85% ₹ ~29,900 ₹ 958 2,282 13.6% 12 ₹
Slide 30: Financial Summary – Profitability Statement (1/2)
Financial Summary – Profitability Statement (1/2) Particulars (INR Cr) FY21 Q2 FY20 Q3 FY21 Q3 Gw% Revenue from operations 2,268 2,322 2,259 -3% Material consumption 687 695 683 Doctors cost 473 501 467 Employee cost (excl. doctors) 413 410 423 Other expenses 424 331 359 EBITDA (excl. other income)
Slide 31: Financial Summary – Profitability Statement (2/2)
Financial Summary – Profitability Statement (2/2) Particulars (INR Cr) FY20 9M FY21 9M Grt% Revenue from operations 6,437 6,287 -2% As at Dec 31, Material consumption 1,938 1,953 Consolidated (INR Cr) 2020 Doctors cost 1,440 1,308 Debt 2,833 Employee cost (excl. doctors) 1,243 1,210 Less: Cash, Bank
Slide 32: Strategy and Leadership
Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 31
Slide 33: ADMHL – Strategy & Outlook (1/2)
ADMHL – Strategy & Outlook (1/2) Strengthening of hub and A comprehensive human Scalable systems Strengthening of our medical spoke model in GCC resource strategy utilizing our implementation, tightly tourism network geographical diversity and integrated with catering to future growth operations/mar
Slide 34: ADMHL – Strategy & Outlook (2/2)
ADMHL – Strategy & Outlook (2/2) Profitability growth & brand Building of brand, talent Specialized, asset-light Cost Optimization positioning using product- and capability in KSA – a growth in India mix and technology key market in GCC • Focus on margin expansion through • There is significant dema
Slide 35: India Strategy
India Strategy India is geographically well positioned for Focus on In line with medical tourism focus on large format from the GCC hospitals in Tier 1 derisking states, MENA business – cities – Hospitals region and South- in Tier 1 cities The new National Health Protection Scheme target of 25% East
Slide 36: Aster Leadership Team
Aster Leadership Team Dr. Azad Moopen Chairman and Managing Director Alisha Moopen T. J. Wilson Group Head – Governance and Veneeth Purushotaman Deputy Managing Director Group Chief Information Officer Corporate Affairs, GCC Dr. Harish Pillai Sreenath Reddy Fara Siddiqi Chief Executive Officer –Aste
Slide 37: Aster Board of Directors
Aster Board of Directors strategy andleadership Daniel Robert Dr Layla Mohamed Dr. Azad Moopen Mintz Chairman and Managing Director Al-Marzooqi Non-Executive Director Independent Director Shamsudheen Bin Alisha Moopen C. John George Deputy Managing Director Mohideen Mammu Haji Independent Director N
Slide 38: www.asterdmhealthcare.com
www.asterdmhealthcare.com